Effect of a Novel Food Rich in Miraculin on the Intestinal Microbiome of Malnourished Patients with Cancer and Dysgeusia
Autor:
Plaza-Diaz, Julio
; Brandimonte-Hernández, Marco
; López-Plaza, Bricia
; Ruiz-Ojeda, Francisco Javier
; Álvarez-Mercado, Ana Isabel
; Arcos-Castellanos, Lucía
; Feliú-Batlle, Jaime
; Hummel, Thomas
; Palma-Milla, Samara
; Gil, Angel
Fecha:
10/01/2025Palabra clave:
Revista / editorial:
NutrientsCitación:
Plaza-Diaz, J., Brandimonte-Hernández, M., López-Plaza, B., Ruiz-Ojeda, F. J., Álvarez-Mercado, A. I., Arcos-Castellanos, L., Feliú-Batlle, J., Hummel, T., Palma-Milla, S., & Gil, A. (2025). Effect of a Novel Food Rich in Miraculin on the Intestinal Microbiome of Malnourished Patients with Cancer and Dysgeusia. Nutrients, 17(2), 246. https://doi.org/10.3390/nu17020246Tipo de Ítem:
articleDirección web:
https://www.mdpi.com/2072-6643/17/2/246
Resumen:
Background/Objectives: Dysgeusia contributes to malnutrition and worsens the quality of life of patients with cancer. Despite the different strategies, there is no effective treatment for patients suffering from taste disorders provided by the pharmaceutical
industry. Therefore, we developed a novel strategy for reducing side effects in cancer patients by providing a novel food supplement with the taste-modifying glycoprotein miraculin, which is approved by the European Union, as an adjuvant tomedical–nutritional
therapy. Methods: A pilot randomized, parallel, triple-blind, and placebo-controlled intervention clinical trial was carried out in which 31 malnourished patients with cancer and dysgeusia receiving antineoplastic treatment were randomized into three arms—standard
dose of dried miracle berries (DMBs) (150 mg DMB/tablet), high dose of DMBs (300 mg DMB/tablet), or placebo (300 mg freeze-dried strawberry)—for three months. Patients consumed a DMB or placebo tablet before each main meal (breakfast, lunch, and dinner).
Using stool samples from patients with cancer, we analyzed the intestinal microbiome via nanopore methodology. Results: We detected differences in the relative abundances of genera Phocaeicola and Escherichia depending on the treatment. Nevertheless, only the
Solibaculum genus was more abundant in the standard-dose DMB group after 3 months. At the species level, Bacteroides sp. PHL 2737 presented a relatively low abundance in both DMB groups, whereas Vescimonas coprocola presented a relatively high abundance in both treatment groups after 3 months. Furthermore, a standard dose of DMB was positively associated with TNF-α levels and Lachnoclostridium and Mediterraneibacter abundances, and a high dose of DMB was negatively associated with TNF-α levels and the relative abundance of Phocaeicola. Following the administration of a high dose of DMB, a positive correlation was observed between erythrocyte polyunsaturated fatty acids and the presence of Lachnoclostridium and Roseburia. Additionally, a positive association was identified between Phocaeicola and the acetic acid concentration of feces. There was a negative association between the relative abundance of Phocaeicola and taste perception in the highdose DMB group. Conclusions: The combination of DMB intake with nutritional treatment and individualized dietary guidance results in positive changes in the intestinal microbiome of patients with cancer and dysgeusia. Changes observed in the intestinal microbiome might contribute to maintaining an appropriate immune response in cancer patients. As the current pilot study included a limited number of participants, further clinical trials on a larger group of patients are needed to draw robust findings.
Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(es)
Estadísticas de uso
Año |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
Vistas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
37 |
Descargas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
23 |
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
I Congreso Español de Videojuegos 2022
González Calero, Pedro Antonio; Gómez Martín, Marco Antonio; Gómez Martín, Pedro Pablo; Gutiérrez Manjón, Sergio; Gutiérrez Sánchez, Pablo; Peinado, Federico; Sánchez-Ruiz Granados, Antonio; Barbancho, Isabel; Blanco Bueno, Carlos; Botella Nicolás, Ana María; Chover, Miguel; Díaz Álvarez, Josefa; Echeverría, Jorge; Fernández Leiva, Antonio J.; Fernández Ruiz, Marta; Gallego-Durán, Francisco; García Sánchez, Pablo; Gutiérrez Vela, Francisco L; Lara-Cabrera, Raúl; León, Carlos; Moreno, Jorge L.; Lozano Muñoz, Alejandro; Mayor, Jesús; Medina Medina, Nuria; Mejías-Climent, Laura; Mora, Antonio M; Munarriz, Jaime; Patow, Gustavo A.; Sagredo-Olivenza, Ismael; Salinas, María-José; Sanchez I. Peris, Francesc Josep; Sánchez-Ruiz, Antonio A; Shliakhovchuk, Elena; Tejada, Jesus (CEUR Workshop Proceedings, 2022){Resumen no disponible] -
Expanding the clinical and genetic spectrum of SQSTM1-related disorders in family with personality disorder and frontotemporal dementia
Llamas-Velasco, Sara; Arteche-López, Ana; Méndez-Guerrero, Antonio; Puertas-Martín, Verónica ; Quesada Espinosa, Juan Francisco; Lezana Rosales, Jose Miguel; González-Sánchez, Miguel; Blanco-Palmero, Victor Antonio; Palma Milla, Carmen; Herrero-San Martín, Alejandro; Borrego-Hernández, Daniel; García-Redondo, Alberto; Pérez-Martínez, David Andrés; Villarejo-Galende, Alberto (Taylor and Francis Ltd., 2021)Objective:SQSTM1-variants associated with frontotemporal lobar degeneration have been described recently. In this study, we investigated a heterozygous in-frame duplication c.436_462dup p. (Pro146_Cys154dup) in the SQSTM1 ... -
Celiac Disease: Beyond Diet and Food Awareness
Herrera-Quintana, Lourdes; Navajas-Porras, Beatriz; Vázquez-Lorente, Héctor; Hinojosa-Nogueira, Daniel; Corrales-Borrego, Francisco J.; Lopez-Garzon, Maria; Plaza-Diaz, Julio (MDPI, 2025)Celiac disease is attributable to a combination of genetic predisposition and exposure to dietary gluten, with immune system involvement. The incidence is increasing globally, and the societal economic burden of celiac ...